Merck (MRK) reported Q1 FY2024 earnings of $2.07 per share (versus $1.40 per share in Q1 FY2023), beating analysts’ consensus estimate of $1.90 per share.
The company’s quarterly revenues amounted to $15.775 bln (+8.9% y/y), beating analysts’ consensus estimate of $15.205 bln.
MRK rose to $129.99 (+2.35%) in pre-market trading.